Targeting CAFs-Secreted TGFβ1 Signaling to Radiosensitize Esophageal Squamous Cell Carcinoma in Vitro and in Vivo

H. Zhang,J. Yue,Z. Jiang,H. Wu,X. Zhang,L. Yang,M. Jiang,Y. Hua,Y. Li,M. Huang,Q. Hou,W. Li,S. Wu

DOI: https://doi.org/10.1016/j.ijrobp.2017.06.346

2017-01-01

Abstract:Radiotherapy is one common curative treatment choice for esophageal squamous cell carcinoma (ESCC) patients. Several studies have demonstrated that CAFs (cancer-associated fibroblasts), a main component of tumor microenvironment, are involved in tumor response to chemoradiotherapy. Our study aimed to explore whether CAFs affected tumor radiosensitivity in ESCC. By primary culture, two pairs of CAFs and matched NFs (normal fibroblasts) had been successfully isolated from tumor tissues of ESCC patients and matched normal esophageal epithelial tissues, respectively. The association of CAFs and radioresistance was assessed in esophageal cancer cells, in xenograft tumor models and in clinical specimens of ESCC patients. Our study found that TGFβ1 was highly expressed in two pairs of CAFs compared with in their matched NFs. Furthermore, Elisa assay showed that TGFβ1 concentration in the culture medium of two pairs of CAFs was significantly higher than in their matched NFs as well as in esophageal cancer cells KYSE-30 and KYSE-180. CAFs-secreted TGFβ1 conferred KYSE-30 and KYSE-180 significant radioresistance by inducing epithelial-mesenchymal transition (EMT) with epithelial marker E-cadherin down-regulated and mesenchymal marker vimentin up-regulated. Mechanical studies revealed that CAFs-secreted TGFβ1 induced EMT in a smad2/3-slug-axis-dependent manner. Furthermore, we found that TGFβ1 was expressed in an autocrine/paracrine signaling loop during the co-culture of CAFs and esophageal cancer cells, leading to enhanced resistance of esophageal cancer cells to radiotherapy. Inhibition of TGFβ1 expression in CAFs by transfection with TGFβ1-against siRNA significantly reversed CAFs-conferred radioresistance with increased DNA double-strand breaks (DSBs) and apoptotic cell death in KYSE-30 and KYSE-180 following radiation. Stable down-regulation of TGFβ1 expression in CAFs significantly decreased clonogenic survival of esophageal cancer cells following radiation and inhibited the growth of xenograft tumor models by transduction with lentivirus vectors containing TGFβ1-against shRNA. In 150 ESCC patients, TGFβ1 was found to be highly expressed in CAFs in comparison with in tumor cells and significantly associated with the prognosis of patients treated with chemoradiotherapy. Our study discovered CAFs-secreted TGFβ1 as a potent molecular target to radiosensitize ESCC in vitro and in vivo.